The Edit · Founder Insights
Keep muscle on a GLP-1 by lifting twice a week, hitting a daily protein floor, sleeping, and training the off-ramp. A doctor-backed guide.

To keep muscle while you lose weight on semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), do three things from the first dose: train against resistance at least twice a week, eat to a protein floor of roughly 1.6 grams per kilogram of body weight a day spread across meals, and protect your sleep. The reason it matters is that a meaningful share of the weight you lose on these drugs is lean mass, not fat: across trials, the drop in fat-free mass accounted for 25 to 39 percent of total weight lost over 36 to 72 weeks (Prado et al., 2024). The medication handles appetite. Holding on to muscle is the half you have to train for.
TL;DR
- On a GLP-1, 25 to 39 percent of the weight you lose is lean mass, not fat (Prado et al., 2024).
- That figure tracks the size of the weight loss, not a unique drug effect, and includes water and organ mass, so it is not pound-for-pound worse than dieting.
- Resistance training twice a week is the single biggest lever for keeping muscle while you lose fat.
- Aim for a daily protein floor near 1.6 g/kg, split into 30 to 40 gram doses, even when appetite is low.
- Sleep, dose-day timing, and a planned off-ramp decide how much of your loss is muscle versus fat.
In this article
- 1. Why muscle goes when the weight comes off the lean-mass cost, read honestly
- 2. Resistance training is the non-negotiable the one habit that changes the ratio
- 3. Hit a daily protein floor how much, and why distribution matters
- 4. Work with dose-day appetite, not against it timing food and training around the cycle
- 5. Train to progress, not to punish why intensity beats volume on low fuel
- 6. Protect your sleep the overlooked driver of where the loss comes from
- 7. Monitor the right numbers scale weight hides the story; track strength and composition
- 8. Plan the off-ramp before you need it protecting muscle when you taper or stop
GLP-1 receptor agonists like semaglutide and tirzepatide changed obesity treatment by doing something diets struggle with: they quieten appetite enough to produce large, sustained weight loss. In the STEP 1 trial, once-weekly semaglutide 2.4 mg produced a mean body-weight reduction of 14.9 percent at 68 weeks, against 2.4 percent on placebo (Wilding et al., 2021). For many people that is life-changing for blood pressure, blood sugar, joints, and mobility.
The catch sits in the body composition. Rapid weight loss from any cause, surgery, very-low-calorie dieting, or these medications, costs lean tissue as well as fat. The commentary that put a number on it for GLP-1s found that the fall in fat-free mass made up 25 to 39 percent of total weight lost across studies (Prado et al., 2024). After 40, that matters more than it sounds, because muscle is the tissue that carries you through the decades: it drives metabolic health, glucose handling, balance, and independence.
It is worth being clear about who this matters most for. If you are in your forties or older, you are already losing muscle slowly to age, so a phase of rapid weight loss layered on top is the moment to defend lean tissue hardest, not to let it slide. Muscle after 40 is the tissue that keeps your metabolism resilient, your blood sugar steady, and your body capable for the decades ahead, which is why a doctor-led approach treats the muscle question as central to the medication, not as an afterthought to it.
The good news is that the muscle cost is not fixed. It responds to what you do alongside the drug. This guide walks through the concrete, evidence-based things that protect muscle on a GLP-1, in the order they matter, so the weight you lose is fat and the strength you keep is yours.
1. Why muscle goes when the weight comes off
The problem people fear is that these drugs specifically attack muscle. They do not. The lean-mass loss you see on a GLP-1 is overwhelmingly a function of how much weight you are losing and how fast, not a toxic effect of the molecule on muscle tissue. When the body runs a large energy deficit, it draws on both fat and lean stores, and the bigger the loss, the more lean tissue comes with it. That is true of dieting and bariatric surgery too.
The honest framing matters here, because scare headlines overstate the case. First, the 25 to 39 percent figure for fat-free mass loss (Prado et al., 2024) is not all contractile muscle. Fat-free mass also includes water, glycogen, and the mass of organs that shrink as a large body gets smaller, so the pure muscle component is smaller than the headline number suggests. Second, non-drug caloric restriction with smaller weight loss produces fat-free-mass losses in a similar 10 to 30 percent range, so a GLP-1 is not uniquely bad on a pound-for-pound basis. What is different is the scale: because these drugs produce so much more weight loss than willpower diets, the absolute kilograms of lean tissue at stake are larger.
The solution is to treat muscle as a stimulus problem, not a drug problem. Muscle responds to demand. Remove demand, lose nothing you do not use, and a body in a deficit will happily let underused muscle go. Keep demand high through resistance training and adequate protein, and the same deficit is forced to take a far greater share of its fuel from fat. This is exactly why the rest of this guide leads with training and protein rather than with the medication.
We see the principle play out in the studio. A member in his fifties came to us three months into Mounjaro, down twelve kilograms and quietly worried his arms looked smaller. His four-pillar baseline confirmed it: strength had slipped even as the scale fell. Twelve weeks of twice-weekly resistance work and a protein target later, his strength numbers were back above where he started while the fat loss continued. Nothing about his medication changed. What changed was the demand signal his muscle was receiving.
The bonus insight is that the muscle you protect now pays compounding returns later. Lean mass is the engine behind your resting metabolism and your ability to handle carbohydrates, so keeping it through the weight-loss phase makes the maintenance phase easier and makes the day you eventually taper the drug far less risky. You are not just defending muscle. You are defending the metabolism that holds the result. For the full mechanism, see our explainer on GLP-1 muscle loss.
2. Resistance training is the non-negotiable
The single most common mistake on a GLP-1 is to lean entirely on walking and cardio. Walking is excellent for appetite, mood, and heart health, and you should keep doing it. But cardio alone does not send muscle the keep-me signal it needs during a deficit, so the scale falls while strength quietly drains away with it.
The solution is resistance training, and the evidence here is unusually clean. In a controlled trial of older adults losing weight, the group that did aerobic exercise alone lost 5 percent of their lean mass, while the resistance and combined-exercise groups lost only 2 to 3 percent, and the resistance and combined groups also preserved hip bone density far better (Villareal et al., 2017). Same deficit, same weight loss, very different body composition, decided by whether the training included lifting. In a separate one-year trial, pairing exercise with a GLP-1 drug cut body-fat percentage roughly twice as much as the drug alone and held the result better than either approach on its own (Lundgren et al., 2021).
The specifics do not need to be elaborate. Two to three full-body resistance sessions a week, covering a push, a pull, a squat or hinge for the legs, and something to load the trunk, is enough to change the ratio for most people. The load needs to be challenging, meaning the last two or three repetitions of a set are genuinely hard, because muscle responds to effort, not to going through the motions. Machines, dumbbells, resistance bands, or bodyweight progressions all work; what matters is that the difficulty climbs over time. If you want to see roughly how much lean mass is at stake for your own weight loss, our free GLP-1 Muscle-Loss Calculator estimates it from your numbers.
In practice, the people who keep the most muscle are the ones who anchor lifting as the fixed point of the week and let walking fill the gaps, not the other way round. One member treated her two studio sessions like medical appointments she would not cancel, and built her cardio around them. A year into Wegovy she had lost the fat she wanted and added strength, because the priority order was right.
The bonus insight is that resistance training does more than hold muscle: it improves how your body handles glucose and protects the bone you also lose during rapid weight loss. It is the one intervention that defends all of the tissues a large deficit puts at risk at once. This is the spine of our GLP-1 Muscle Protocol, the structured programme built specifically for people losing weight on these medications.
3. Hit a daily protein floor
The problem GLP-1s create for protein is mechanical: they work by suppressing appetite, and protein is the most filling macronutrient, so it is the first thing people unconsciously cut. Meals shrink, and the protein shrinks fastest, which is precisely backwards for someone trying to keep muscle.
The solution is to treat protein as a floor you hit on purpose rather than an amount you happen to eat. For an adult doing resistance training during weight loss, a practical target is around 1.6 grams of protein per kilogram of body weight per day. Older adults in particular need more than the standard guideline because ageing muscle is less responsive to protein, which is why expert consensus recommends at least 1.0 to 1.2 grams per kilogram for older people even without dieting, and more during a deficit (Bauer et al., 2013). On a strong appetite suppressant, hitting that number takes planning, not appetite.
Distribution is the specific that most people miss. Muscle protein synthesis responds best to roughly 30 to 40 grams of protein in a sitting, so spreading intake across three or four meals beats loading it all at dinner, which is the default when appetite only shows up late in the day. Front-load protein at breakfast while the medication's appetite effect is often weaker, lean on dense sources like eggs, dairy, fish, poultry, tofu, and legumes, and use a protein shake on the days a full meal feels impossible. The shake is not a supplement gimmick here; it is a tool for hitting a floor that food volume alone will not reach when you are barely hungry.
We have watched this single change rescue results. A member on semaglutide was losing weight fast but feeling weak and flat. Her food diary showed she was eating well under half her protein target simply because nothing appealed. We did not add calories; we redistributed them toward protein and added one daily shake. Within weeks her gym sessions had energy again and her strength stopped sliding. The deficit was the same. The building blocks were finally there.
A simple way to operationalise the floor is to build every meal around a palm-sized portion of a dense protein first, then add the rest. On a strong appetite suppressant, stomach space is the scarce resource, so spending it on protein before bread, rice, or sauces ensures the muscle-protecting nutrient is the part that actually gets eaten. People who plan the protein first and let everything else fill the remaining room hit their target far more consistently than people who eat normally and hope the protein adds up, because on these medications it rarely does.
The bonus insight is that protein is also the most satiating and the most thermogenic macronutrient, so prioritising it tends to make appetite control easier and protects against the late-day overeating that can undo a low-appetite day. It works with the medication rather than against it.
4. Work with dose-day appetite, not against it
Anyone on a weekly injection knows the rhythm: appetite is often most suppressed in the day or two after the dose and returns as the week goes on. The problem is that people fight this cycle, forcing food when they cannot eat and then overcorrecting later, which leaves protein and training fuel scattered unpredictably across the week.
The solution is to plan around the cycle instead of resisting it. On the low-appetite days right after a dose, lower the bar to liquid and soft protein you can get down without a big meal: a shake, Greek yoghurt, soup with added protein, eggs. On the days appetite returns, that is when a proper protein-forward meal and your hardest training session are easiest to deliver. You are not eating more across the week; you are placing your protein and your effort where your body can actually accept them.
The specific worth knowing is that you do not have to train hard on the flattest days. Muscle is kept by the weekly total stimulus, not by any single session, so if the day after your injection leaves you depleted, a light walk and a shake is a perfectly good day. Move the demanding lifting to the part of the week when you have fuel and appetite. This rhythm is one of the chapters in our GLP-1 Muscle Protocol precisely because it is the difference between a programme that survives real life and one that collapses the first low week.
In the studio we schedule around it openly. A member who injects on Sunday books his two resistance sessions for Wednesday and Friday, when his appetite and energy are reliably back, and treats the early week as recovery and walking. His protein intake is steadier for it, because he stopped trying to force a steak down on a day his body wanted soup.
A practical way to map the week is to label your days. The one or two days after the injection are recovery days: walking, mobility, and easy-to-swallow protein. The middle of the week, when appetite and energy return, holds your two resistance sessions and your most protein-dense meals. The tail end, before the next dose, is a buffer where you catch up on anything you missed. The same total stimulus and the same protein floor land far more reliably when they are placed against the rhythm rather than smeared evenly across seven days that are not actually the same.
The bonus insight is that the appetite cycle usually softens as you settle on a maintenance dose, so the timing discipline you build early becomes easier over time. It is a temporary skill, not a permanent burden, and the habit of placing protein and effort deliberately serves you long after the medication's edge has smoothed out.
5. Train to progress, not to punish
A trap people fall into when they have less appetite and less fuel is to make training harder and longer to compensate, treating exercise as a way to burn off worry. On a calorie deficit with a suppressed appetite, that backfires: long, grinding sessions add fatigue without adding the specific signal muscle needs, and they make recovery harder when recovery is already constrained.
The solution is to train for progression on a small number of key lifts rather than for exhaustion. Muscle is preserved by lifting loads that are meaningfully challenging, not by accumulating endless repetitions. A focused session of a few compound movements, each taken close to the point where the last repetitions are genuinely difficult, does more to keep muscle than an hour of light circuits. Quality of effort is the active ingredient.
The specific to track is whether the work is getting harder over time in a controlled way: a little more weight, a clean extra repetition, a steadier tempo. That progression is the proof that muscle is still being asked to adapt. When you are eating less, this efficiency matters even more, because you cannot afford to spend your limited recovery on junk volume that does not earn its keep. The same principle that drives sensible body recomposition after 40 applies here, only with a medication doing the appetite work for you.
We coach this directly. A member arrived convinced he needed marathon gym sessions to offset eating so little. We cut his session length, raised the difficulty of his main lifts, and his strength started climbing within a month while he felt less wrecked. He was doing less and keeping more, because the stimulus finally outweighed the fatigue.
The bonus insight is that this approach is also the most sustainable. People stick to two or three sharp sessions a week far longer than they stick to daily punishment, and consistency over months is what actually protects muscle through a long weight-loss phase. The best programme is the one you are still doing in a year.
6. Protect your sleep
Sleep is the lever almost nobody connects to muscle, and it is one of the most powerful. The problem is that during a weight-loss push, sleep is the first thing people sacrifice, assuming it only affects how tired they feel. It does far more than that: it helps decide whether the weight you lose comes off as fat or as muscle.
The evidence is striking. In a controlled study, dieters who slept 5.5 hours a night instead of 8.5 lost the same total weight, but the proportion of that loss coming from fat dropped by more than half, and the loss of fat-free mass rose by around 60 percent (Nedeltcheva et al., 2010). Same diet, same scale result, dramatically worse body composition, driven by sleep alone. On a GLP-1, where you are already managing a lean-mass cost, short sleep stacks directly onto the problem.
The specific actions are unglamorous and effective: a consistent sleep and wake time, a genuine target of seven to nine hours in bed, a dark cool room, and a wind-down that gets screens and late stimulants out of the way. If reflux or nausea from the medication disrupts your nights early on, an earlier last meal and not lying down straight after eating often helps. None of this is exotic, which is exactly why it gets skipped, and exactly why fixing it gives you an edge most people never claim.
We treat sleep as a training variable in our assessments for this reason. One member's strength had stalled despite doing everything else right; the missing piece was five-hour nights from work stress. Once we helped her protect a proper sleep window, her sessions and her recovery improved together, and her composition followed.
The bonus insight is that sleep also blunts the hunger and reward signals that make low-appetite discipline harder to sustain, so protecting it supports both halves of the equation: it keeps more of your loss as fat and makes the eating plan easier to hold. It is the cheapest performance enhancer you own.
7. Monitor the right numbers
The problem with judging a GLP-1 by the bathroom scale is that the scale cannot tell muscle from fat. A falling number feels like success, but if a chunk of that fall is lean tissue, you are getting lighter and weaker at the same time, and the scale will cheerfully hide it from you until your strength or your shape tells the truth.
The solution is to track the metrics that actually reflect what you care about: how much you can lift, how you move, and your body composition, not just total weight. Strength is the most accessible proxy you have. If your key lifts are holding or climbing while the scale falls, you are losing fat and keeping muscle, which is exactly the outcome you want. If your lifts are dropping in step with your weight, that is the early warning to add training stimulus and protein before more muscle goes.
The specific tools matter less than the consistency of using them. A periodic body-composition measurement, a simple grip-strength or repetition benchmark, and a photo every few weeks together tell a far richer story than weight alone. This is the reasoning behind our 4-Pillar Healthspan Assessment, which measures body composition, cardiorespiratory fitness, stability, and strength, so you can see whether the weight you are losing is the weight you wanted to lose. Closely related is the bone you also risk losing in rapid weight loss, covered in our piece on GLP-1s and bone density.
In practice, this reframing changes behaviour. A member fixated on the scale was demoralised when the number plateaued, ready to quit. His assessment showed the plateau was muscle gain offsetting continued fat loss: he was recomposing, not stalling. Seeing the real picture kept him in the programme, and the visible change followed.
The bonus insight is that measuring strength and composition also protects you from the opposite error, of cutting too aggressively. If your benchmarks fall sharply, that is the signal to ease the deficit or eat more protein. Good data lets you steer instead of guess.
8. Plan the off-ramp before you need it
The problem most people do not see coming is what happens when the medication stops. GLP-1s manage weight while you take them, but the effect is not permanent: in the STEP 1 extension, participants regained about two-thirds of their lost weight in the year after stopping semaglutide (Wilding et al., 2022). The danger is that the regain comes back disproportionately as fat, while the muscle you lost on the way down does not automatically return, leaving you heavier in fat and lighter in muscle than where you finished.
The solution is to have built the muscle-protecting habits before you taper, not to start scrambling once you are off. If resistance training twice a week and a protein floor are already routine while you are on the drug, they become the structure that holds your result when appetite returns and the chemical brake comes off. The training and eating habits, not the injection, are what make weight loss durable. This is the entire logic of treating the medication as a window to build capacity rather than a permanent crutch.
The specifics of a sensible off-ramp are a gradual taper rather than an abrupt stop where your clinician agrees, appetite-management strategies for the return of hunger, and an unwavering commitment to keep lifting and keep hitting protein. The people who hold their loss are almost always the ones who used their time on the medication to become genuinely stronger and more capable, so that the body they keep is one their habits can maintain. We cover this transition in depth in our guide to coming off a GLP-1 without regaining fat.
We plan for this from the first session, not the last. A member who knew she would only be on her medication for a year spent that year building a resistance-training habit she actually enjoyed. When she tapered off, her weight held, because the thing keeping it off was no longer in the syringe. It was in her week.
The bonus insight is that planning the off-ramp early changes how you train throughout: every session becomes an investment in the maintenance phase, which makes the whole programme feel purposeful rather than like damage control. You are not just losing weight. You are building the body that keeps it.
How to pick what to do first
If you do nothing else, start resistance training and lock in a protein floor. Those two levers move the muscle-versus-fat ratio more than anything else on this list, and they are within your control from your very first dose. Two challenging full-body sessions a week and a deliberate protein target turn a deficit that would erode muscle into one that mostly burns fat. Everything else, sleep, dose-day timing, monitoring, the off-ramp, multiplies the return on those two foundations.
After that, the order depends on where your gaps are, which is exactly what an objective baseline is for. Rather than guess, measure. The 4-Pillar Healthspan Assessment gives you a clear read on your body composition and strength so you know whether the priority is adding training stimulus, fixing protein, or protecting recovery. You cannot manage what you have not measured, and on a medication that hides muscle loss behind a falling scale, that baseline is the difference between guessing and steering.
From there it becomes maintenance and monitoring. Re-check your strength and composition every couple of months, adjust protein and training as the numbers tell you, and keep the off-ramp in view from the start. The aim throughout is simple: make the weight you lose fat, and make the strength you build something your habits can hold long after the medication has done its part.
The medication handles your appetite. Keeping your muscle is the half you have to train for, and it is the half that decides whether the result lasts.
Frequently asked questions
Q. How do I keep muscle on semaglutide?
Do resistance training at least twice a week, eat to a daily protein floor of around 1.6 grams per kilogram of body weight spread across meals, and protect your sleep. The medication manages your appetite and drives the weight loss; lifting and protein are what tell your body to lose fat rather than muscle. In controlled trials, the exercise group that lifted preserved far more lean mass than the group doing cardio alone for the same weight loss (Villareal et al., 2017). Start those two habits from your first dose rather than waiting until you notice strength slipping.
Q. How much muscle do you lose on Ozempic or Mounjaro?
Across studies, the fall in fat-free mass accounted for 25 to 39 percent of total weight lost over 36 to 72 weeks (Prado et al., 2024). Read that honestly: fat-free mass includes water and organ mass, so the pure muscle component is smaller, and the figure tracks the size of the weight loss rather than a unique drug effect, which means resistance training and protein can substantially reduce it. The risk is real but it is not fixed. What you do alongside the medication decides how much of that lean-mass cost you actually pay.
Q. Will I lose muscle if I do not exercise on a GLP-1?
You are likely to lose more muscle without resistance training than with it. Cardio and walking are good for your heart and appetite but do not give muscle the demand signal it needs during a calorie deficit, so a body losing weight will let underused muscle go. The trial evidence is clear that lifting changes the ratio: same weight loss, far better lean-mass retention (Villareal et al., 2017). If you can do only one form of exercise on a GLP-1, make it resistance training.
Q. What happens to my muscle when I stop the medication?
Weight tends to return after stopping, with about two-thirds of the loss regained within a year in the STEP 1 extension (Wilding et al., 2022), and the regain can skew toward fat while the lost muscle does not come back on its own. That is why the muscle-protecting habits matter most before you taper: if resistance training and a protein floor are already routine, they become the structure that holds your result when appetite returns. Plan the off-ramp from the start, not when you are already off.
Keeping muscle on a GLP-1 is not complicated, but it is deliberate. Lift twice a week, hit a protein floor, sleep, work with the dose-day rhythm, measure the right numbers, and build the habits before you taper. Do that, and the medication becomes a window to get genuinely stronger rather than a trade of fat for muscle. For the deeper mechanism see our explainer on GLP-1 muscle loss, and if you are weighing whether you still need coaching while on the drug, read do you still need a trainer on Ozempic.
If you want a structured plan built for exactly this situation, the GLP-1 Muscle Protocol turns these principles into a week-by-week programme, and a complimentary 4-Pillar Healthspan Assessment gives you the body-composition and strength baseline to steer by. You can book a consultation to talk it through with a coach.
Citations
Prado CMM, Phillips SM, Gonzalez MC, Heymsfield SB. Muscle matters: the effects of medically induced weight loss on skeletal muscle. The Lancet Diabetes & Endocrinology. 2024;12(11):785-787.
Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384(11):989-1002.
Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022;24(8):1553-1564.
Villareal DT, Aguirre L, Gurney AB, et al. Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults. New England Journal of Medicine. 2017;376(20):1943-1955.
Lundgren JR, Janus C, Jensen SBK, et al. Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. New England Journal of Medicine. 2021;384(18):1719-1730.
Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. Journal of the American Medical Directors Association. 2013;14(8):542-559.
Nedeltcheva AV, Kilkus JM, Imperial J, Schoeller DA, Penev PD. Insufficient sleep undermines dietary efforts to reduce adiposity. Annals of Internal Medicine. 2010;153(7):435-441.
